RDNT

SEC Filing Summary: Primedex Health Systems, Inc. (10-Q)

Business Context and Reporting Period

This Form 10-Q covers the quarterly and six-month periods ended April 30, 1998, for Primedex Health Systems, Inc. (PHS). The registrant operates diagnostic imaging centers through subsidiaries including Radnet, Diagnostic Imaging Services (DIS), and Radnet Managed Imaging Services (RMIS). The financial statements are unaudited and reflect significant divestitures and restructuring activities during the period.

Key Financial Metrics

Note: Total Debt includes Notes/Leases Payable and Subordinated Debentures. Working Capital Deficit is calculated as Current Assets minus Current Liabilities.

Material Changes vs. Prior Period

• Revenue Decline: Net revenue decreased by approximately $5.1 million (14.6%) year-over-year. This is primarily due to the sale of DIS's ultrasound division, four MRI facilities, and the Scripps Chula Vista (SCV) partnership to Diagnostic Health Services (DHS), as well as the closure of the Parkside facility.
• Improved Operating Performance: Operating loss narrowed significantly from $5.36 million to $0.35 million. The prior year included a $4.95 million impairment loss related to the Parkside closure, which was not present in the current period.
• Divestitures and Gains: The company recognized a $340,710 gain on the sale of subsidiaries in the current period, compared to a $5.59 million gain in the prior year. Additionally, an extraordinary gain of $961,885 was recorded from the early extinguishment of debt.
• Accounting Change: Adoption of SOP 98-5 resulted in a $780,000 write-off of start-up costs, increasing the net loss by $0.02 per share.

Outlook, Risks, and Contingencies

• Liquidity Constraints: The company maintains a significant working capital deficit of $18 million. Liquidity is supported by two lines of credit totaling $15 million, with approximately $13.6 million outstanding as of April 30, 1998. These lines are secured by accounts receivable and personal guarantees from the CEO.
• Debt Obligations: Future debt and capital lease payments over the next five years are projected to total approximately $86 million (excluding lines of credit). Interest expense remains high, though reduced from the prior year due to debt repurchases.
• Operational Consolidation: Three Tower locations in Beverly Hills are scheduled to consolidate into a new Wilshire location in fiscal 1999 to reduce rental costs by approximately $1 million annually. Management notes uncertainty regarding potential volume impacts from this move.
• Legal Contingencies: The company is a defendant in a securities class action ("In re Hibbard Brown & Company"). A preliminary settlement of $240,000 was reached in 1996, but final court approval is pending. Management expects no additional costs beyond the settlement amount.
• Subsequent Events: Post-period, the company sold DHS stock received from the SCV transaction for a loss of approximately $202,000, but realized a gain of approximately $496,000 from the sale of other DHS stock related to prior MRI facility sales.

Investor Verification Checklist

• Debt Covenants: Verify compliance with the $15 million lines of credit, specifically the borrowing bases tied to eligible accounts receivable and the personal guarantees provided by the CEO.
• Asset Quality: Review the composition of Accounts Receivable ($18M current, $6.5M non-current) given the history of write-offs and contractual adjustments mentioned in the MD&A.
• Related Party Transactions: Confirm the status of loans to officers (totaling over $1M) and the terms of the stock subscription and option exercises involving former officers.
• Future Cash Flow: Assess the ability to service the $86 million in future debt/lease obligations given the current negative operating cash flow of $2.6 million for the six-month period.
• Consolidation Impact: Monitor the revenue performance of the three Beverly Hills centers post-consolidation into the new Wilshire facility in fiscal 1999.